requires daily injections compared to weekly with others
Sndergrd SD, Cintin I, Kuhlman AB, Morville TH, Bergmann ML, Kjr LK, Poulsen HE, Giustarini D, Rossi R, Dela F, Helge JW
Clinical trials have demonstrated substantial reductions in hemoglobin A1c levels (often 1.5-2.5 percentage points, depending on dose) and significant weight loss (approximately 5-20% of baseline body weight, with higher percentages generally seen in non-diabetic populations with obesity)
Reduced risk of chronic diseases: Weight loss can lower blood pressure, cholesterol, and blood sugar levels, decreasing the risk of heart disease, diabetes, and other health issues
Contact us today to begin your journey to improved health and confidence